top of page

Search Results

Results found for "Structure Therapeutics"

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    The models use a variety of data for the input, including amino acid sequences or structural data (from Mutations: ML methods can determine stabilising mutations that enable structure determination and can even where no similar structure is known. 4. revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively activate therapeutically analyzing drug-target interactions and disease pathways, AI can identify potential candidates that may have therapeutic

  • 📰 GPCR Weekly News, February 27 to March 5, 2023

    Function and structure of bradykinin receptor 2 for drug discovery. Structural and Molecular Insights into GPCR Function The activation mechanism and antibody binding mode Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in Industry News Design Pharmaceuticals has a new website Confo Therapeutics Announces Global Licensing Antiverse raises €2.8M for its computational antibody drug discovery platform Antiverse identifies therapeutic

  • 📰 GPCR Weekly News, January 8 to 14, 2024

    MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic bodies as chemical signals for the immune system AI-driven GPCR analysis, engineering, and targeting Structural and Molecular Insights into GPCR Function Characterizing conformational states in GPCR structures using Biotechnology will be presenting at the OBIO 2024 Investment Summit X-rays to AlphaFold: the future structure 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Senior Researcher in Structural

  • 📰 GPCR Weekly News, January 23 to 29, 2023

    Structural and Molecular Insights into GPCR Function Structural and dynamic insights into supra-physiological Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions. Structural and Molecular Determinants for Isoform Bias at Human Histamine H3 Receptor Isoforms. Orbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeutics

  • 📰 GPCR Weekly News - January 9 to 15, 2023

    GPCR Activation and Signaling New simulation insights on the structural transition mechanism of Bovine Structural and Molecular Insights into GPCR Function Thermodynamic architecture and conformational plasticity Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions. Cryo-EM structures of orphan GPR21 signaling complexes. Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research collaborations GPCR Therapeutics

  • Isoform-and ligand-specific modulation of adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder

    The LK30/ADGRL3 complex structure revealed that the LK30 binding site on ADGRL3 overlaps with the binding using unique tools, and thus establishes a foundation for the development of fine-tuned aGPCR-targeted therapeutics

  • Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids

    Despite its therapeutic potential, CB2 pharmacology remains difficult to interrogate with confidence. This dataset highlights how HCS can be used both to triage compound series and to extract quantitative structure–affinity For cannabinoid chemistry programs—where small structural shifts can significantly alter receptor preference or signaling bias—access to live-cell binding information can sharpen structure–activity relationships Three-dimensional quantitative structure–selectivity relationships analysis guided rational design of

  • Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...

    Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic December 2021 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in GPCR-focused structure-based high-quality synthetic DNA using its silicon platform, announced a strategic collaboration to discover therapeutic

  • 📰 GPCR Weekly News, January 30 to February 5, 2023

    Non-canonical Golgi-compartmentalized Gβγ signaling: mechanisms, functions, and therapeutic targets. Structural and Molecular Insights into GPCR Function Structural view of G protein-coupled receptor signaling Cryo-EM structure of orphan G protein-coupled receptor GPR21. Announces First-in-Human Study for Bristol Myers Squibb In-Licensed PKC Theta Inhibitor, EXS4318 GPCR Therapeutics interest’ Addex Strategic Partner Completes Enrollment In Adx71149 Epilepsy Phase 2 Study Part 1 Domain Therapeutics

  • Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors

    Here, we review how nanobodies have been adopted to elucidate the structure, pharmacology, and signaling nanobodies with tailored specificities may expand the impact of these tools for both basic science and therapeutic

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    into the Classified GPCR News from February 26th to March 3rd, 2024 Adhesion GPCRs The repertoire and structure variants assembled from publicly available deep-sequenced human samples GPCR Activation and Signaling Structure-guided and drug discovery in endocrinology and metabolism Reviews, GPCRs, and more Butyrate as a promising therapeutic cadherin G protein-coupled receptors that bind cry toxins of Bacillus thuringiensis Industry News Domain Therapeutics

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    Allosteric modulation of conserved motifs and helices in 5HT2BR: Advances drug discovery and therapeutic GPCRs in Cardiology, Endocrinology, and Taste α1-Adrenergic Receptors: Insights into Potential Therapeutic Structural and Molecular Insights into GPCR Function Structure-based design of novel melanin-concentrating Industry News Josephine (Pina) Cardarelli from GPCR Therapeutics on Beyond Biotech Podcast Crinetics

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    beta-arrestin coupling and intracellular trafficking of metabotropic glutamate receptor homo- and heterodimers Structural protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism GPCR Binders, Drugs, and more Design and structural impact of different detergents and nanodiscs on the A2A adenosine receptor Reviews, GPCRs, and more Structure Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics

  • 📰 GPCR Weekly News, April 24 to 30, 2023

    Adhesion GPCRs Antiparallel dimer structure of CELSR cadherin in solution revealed by high-speed-atomic Tethered agonist activated ADGRF1 structure and signalling analysis reveal basis for G protein coupling Structural and Molecular Insights into GPCR Function Cryo-EM structure of the endothelin-1-ETB-Gi complex GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    drug discovery; new strategies for inflammatory disease treatment; growth strategies from Tectonic Therapeutics and GPCR signaling in cancer at CRCM Must-read publications : AlphaFold3 benchmarking for GPCRs; new structural This misunderstanding leads to: Inefficient structure-activity relationship (SAR) cycles Wasted optimization

  • 📰 GPCR Weekly News

    future perspectives Non-canonical Golgi-compartmentalized Gβγ signaling: mechanisms, functions, and therapeutic Class C G Protein-Coupled Receptor Reviews, GPCRs, and more Life, death and resurrection of plant GPCRs Structural Research Term Of Substance Use Disorder Gabab Positive Allosteric Modulator Discovery Collaboration Domain Therapeutics

  • Targeted Therapies to Reduce Side Effects in Modern Drug Development

    years to uncover the mechanisms of disease before they can even dare to contemplate the development of therapeutic Modern drug development approaches include a range of techniques leveraging structural biology, immunology

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    Notably, innovations in structural biology, such as X-ray crystallography and cryo-electron microscopy For example, Carlsson et al. (2010) utilised structural information and virtual ligand screening to discover While these structural techniques offer significant advantages in drug discovery, no single method can data to contextualise ligand-induced structural changes and reveal the principles underlying efficacy Structure-based discovery of A2A adenosine receptor ligands.

  • A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.

    of both CBRs.[4–8] A key challenge in CBR modulator development is separating the therapeutic effects Chemical structure of [3H-CP-55940]. New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders. Crystal Structure of the Human Cannabinoid Receptor CB1. Crystal Structure of the Human Cannabinoid Receptor CB2.

  • To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...

    Although the high-resolution crystal structures of the DOR with both agonist and antagonist have recently These insights will facilitate further development of therapeutic agents targeting the DOR.Communicated

  • Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered

    Moreover, the study's insights into the structural and functional consequences of specific phosphorylation This knowledge could inform the development of therapeutic strategies aimed at targeting specific phosphorylation These findings enhance our understanding of cellular signaling dynamics and open new avenues for therapeutic

  • Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...

    the Company Through the Next Stage of its Evolution "New team focused on expanding its GPCR-focused structure-based Matt Barnes appointed President of Heptares Therapeutics Ltd., and Head of UK R&D Tokyo, Japan and Cambridge

  • Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists

    It is a therapeutic target because it plays a role in thermogenesis, lipolysis, and bladder relaxation Ligand-based pharmacophore modeling was performed since no 3D structure of human β3 -AR is yet available

  • 📰 GPCR Weekly News, March 6 to 12, 2023

    Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization Structural basis of peptide recognition and activation of endothelin receptors. Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation October 25 - 27, 2023) GPCR Jobs CADD and Informatics Head or Team Lead (depending on experience) with Structural

  • 📰 GPCR Weekly News - January 2 to 8, 2023

    Structural and Molecular Insights into GPCR Function Structural and functional analyses of a GPCR-inhibited Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics

  • 📰 GPCR Weekly News, April 10 to 16, 2023

    Structural and Molecular Insights into GPCR Function Function and dynamics of the intrinsically disordered Allosteric GPCR Drug Discovery from the 2nd Annual GPCRs-Targeted Drug Discovery Summit, Boston MA Pathios Therapeutics Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics presented 3 posters at AACR 2023 Exscientia presented a poster at AACR 2023 Pathios Therapeutics presented Swiss Biotech Day (April 24 - 25, 2023) ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics

  • Accelerating GPCR Drug Discovery

    I was always the one identifying what could be improved: The essential structure that was missing. But without structure, it's just a messy pile of colored blocks. You can't move fast without clarity, and you can't make confident decisions without robust structure. Operational Discipline:  Robust systems and clear structure aren't "nice to have"—they are absolutely

  • 📰 GPCR Weekly News, December 18 to 31, 2023

    more Classifying tetraspanins: A universal system for numbering residues and a proposal for naming structural protein-coupled receptor superfamily in aphids: Contractions and duplications linked to phloem feeding Structural chemokines and antagonists using a nanoscale hCCR3 receptor sensor GPCR-G protein selectivity revealed by structural Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics

  • Dr. GPCR University registration is now open! Secure your spot now!

    Receptor-Selective Fluorescent Probes and Applications in Single-Molecule Microscopy of Wild-Type Receptors Structural the adenosine A2A and cannabinoid CB2 heteromer Mechanistic insights from the atomic-level quaternary structure of short-lived GPCR oligomers in live cells Industry News Confo Therapeutics Announces EUR 60M Series

  • 📰 GPCR Weekly News, February 19 to 25, 2024

    receptor promotes the restoration of tension in epithelial cells GPCR Binders, Drugs, and more Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders Discovery of a Photoaffinity disease virus (LSDV) infection in domestic Himalayan yaks (Bos grunniens) in Himachal Pradesh, India Structural Insights into GPCR Function Exploring Diverse Signaling Mechanisms of G Protein-Coupled Receptors through Structural

bottom of page